InvestorMulti-strategy private equity firm with a global presence.

Sofinnova Partners is a leading European venture capital firm based in Paris, specializing in life sciences investments across the entire value chain. With over €4 billion in assets under management, the firm has supported more than 500 companies since its founding in 1972.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Founded in 1972, Sofinnova Partners is a prominent venture capital firm headquartered in Paris, with additional offices in London and Milan. The firm focuses on life sciences investments, including biopharma, medtech, digital medicine, agriculture, and industrial processes. With over €4 billion in assets under management, Sofinnova Partners has backed more than 500 companies over its 50 years of operation. The firm employs a multi-strategy platform that spans company creation, acceleration, growth, and crossover investing, emphasizing long-term partnerships and a commitment to innovation in healthcare and sustainability.
Sofinnova Partners invests across the entire value chain of life sciences, focusing on biopharma, medtech, digital medicine, agriculture, and industrial processes. Their investment strategies include early-stage biopharma and medtech start-ups, an in-house medtech accelerator, and growth-stage biotech and medtech companies, among others.
Sofinnova Partners adds value to its portfolio companies through deep clinical and regulatory expertise, hands-on support throughout milestones, and access to a strong transatlantic syndicate. The firm is committed to nurturing innovation and facilitating growth in the life sciences sector.
Sofinnova Partners focuses exclusively on life sciences, investing in biopharma, medtech, digital medicine, agriculture, and industrial processes. They seek companies at various stages, from seed to growth, with a strong emphasis on innovation and sustainability.
Founders can submit their projects through the contact page on the Sofinnova Partners website. A project submission form is available for potential investments, and it is advisable to include a detailed business plan and financial projections.
The firm offers deep clinical and regulatory expertise, which is crucial for navigating the complexities of the life sciences sector. Their hands-on support throughout milestones and access to a strong transatlantic syndicate further differentiate them from other investors.
Sofinnova Partners primarily focuses on Europe but is open to global investments, leveraging its strong connections in the transatlantic market.
Sofinnova Partners typically invests between $1 million and $175 million, allowing them to support companies at various stages of development.
Founders can expect hands-on support from Sofinnova Partners, including guidance through clinical and regulatory processes, strategic advice, and access to their extensive network within the life sciences industry.
Superscout Pro
Is this page right?Reviewed · How the research works